AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Jorey Chernett Acquires 105,848 Shares

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett acquired 105,848 shares of the firm’s stock in a transaction dated Monday, March 16th. The shares were purchased at an average cost of $2.43 per share, for a total transaction of $257,210.64. Following the acquisition, the insider directly owned 6,592,059 shares in the company, valued at $16,018,703.37. This represents a 1.63% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Wednesday, March 11th, Jorey Chernett bought 88,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.15 per share, with a total value of $189,200.00.
• On Friday, March 6th, Jorey Chernett bought 45,600 shares of AirSculpt Technologies stock. The shares were purchased at an average price of $2.00 per share, with a total value of $91,200.00.
• On Wednesday, March 4th, Jorey Chernett acquired 30,000 shares of AirSculpt Technologies stock. The stock was acquired at an average price of $1.87 per share, with a total value of $56,100.00.
• On Tuesday, March 3rd, Jorey Chernett purchased 80,000 shares of AirSculpt Technologies stock. The shares were bought at an average cost of $1.71 per share, for a total transaction of $136,800.00.

AirSculpt Technologies Price Performance

Shares of AIRS stock opened at $2.81 on Tuesday. The stock has a 50-day moving average price of $2.23 and a 200 day moving average price of $4.66. The firm has a market cap of $175.14 million, a price-to-earnings ratio of -9.35 and a beta of 2.76. AirSculpt Technologies, Inc. has a 12 month low of $1.51 and a 12 month high of $12.00. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.63.

Institutional Trading of AirSculpt Technologies

Several hedge funds have recently bought and sold shares of AIRS. Citizens Financial Group Inc. RI increased its holdings in shares of AirSculpt Technologies by 49.1% in the second quarter. Citizens Financial Group Inc. RI now owns 147,900 shares of the company’s stock worth $714,000 after purchasing an additional 48,734 shares during the period. Aristides Capital LLC bought a new position in shares of AirSculpt Technologies during the fourth quarter valued at approximately $140,000. EHP Funds Inc. purchased a new stake in shares of AirSculpt Technologies in the 3rd quarter worth about $1,223,000. CenterBook Partners LP lifted its holdings in AirSculpt Technologies by 59.4% in the third quarter. CenterBook Partners LP now owns 355,081 shares of the company’s stock worth $2,848,000 after buying an additional 132,327 shares during the period. Finally, Tradewinds LLC. bought a new stake in shares of AirSculpt Technologies during the third quarter valued at approximately $113,000. Institutional investors and hedge funds own 91.54% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $6.00.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.